INVO Fertility, Inc. Cost of Revenue
INVO Fertility, Inc. (IVF) reported Cost of Revenue of $60.15 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-14
- INVO Fertility, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $60.15K, a 1863.66% increase year-over-year.
- INVO Fertility, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $5.15K, a 29.32% increase year-over-year.
- INVO Fertility, Inc. cost of goods and services sold for the quarter ending 2025-06-30 was $3.06K.
- INVO Fertility, Inc. cost of goods and services sold for the quarter ending 2025-03-31 was $3.98K.
- INVO Fertility, Inc. cost of goods and services sold for fiscal 2025 was $30.57K, a 150.56% increase from fiscal 2024.
- INVO Fertility, Inc. cost of goods and services sold for fiscal 2024 was $12.20K.
- INVO Fertility, Inc. cost of goods and services sold for fiscal 2022 was $286.92K, a 127.13% increase from fiscal 2021.
- INVO Fertility, Inc. cost of goods and services sold for fiscal 2021 was $126.33K, a 59.84% increase from fiscal 2020.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $60.15K 10-Q · filed 2026-08-14 | $65.30K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $5.15K 10-Q · filed 2026-06-22 | |||
| 2025-12-31 | $30.57K 10-K · filed 2026-06-02 | |||
| 2025-06-30 | $3.06K 10-Q · filed 2026-08-14 | $7.05K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $3.98K 10-Q · filed 2026-06-22 | |||
| 2024-12-31 | $12.20K 10-K · filed 2026-06-02 | |||
| 2023-03-31 | $61.29K 10-Q · filed 2023-05-15 | $128.78K derived: sum of 2 quarters · filed 2023-05-15 | $226.37K derived: sum of 3 quarters · filed 2023-05-15 | $290.68K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | $67.49K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $165.08K derived: sum of 2 quarters · filed 2023-04-17 | $229.39K derived: sum of 3 quarters · filed 2023-04-17 | $286.92K 10-K · filed 2023-04-17 |
| 2022-09-30 | $97.59K 10-Q · filed 2022-11-14 | $161.90K derived: sum of 2 quarters · filed 2022-11-14 | $219.43K 10-Q · filed 2022-11-14 | $255.29K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-06-30 | $64.31K 10-Q · filed 2022-08-15 | $121.84K 10-Q · filed 2022-08-15 | $157.70K derived: sum of 3 quarters · filed 2023-05-15 | $175.69K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-03-31 | $57.53K 10-Q · filed 2023-05-15 | $93.39K derived: sum of 2 quarters · filed 2023-05-15 | $111.38K derived: sum of 3 quarters · filed 2023-05-15 | $123.55K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $35.86K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $53.85K derived: sum of 2 quarters · filed 2023-04-17 | $66.01K derived: sum of 3 quarters · filed 2023-04-17 | $126.33K 10-K · filed 2023-04-17 |
| 2021-09-30 | $17.99K 10-Q · filed 2022-11-14 | $30.15K derived: sum of 2 quarters · filed 2022-11-14 | $90.46K 10-Q · filed 2022-11-14 | $98.23K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $12.16K 10-Q · filed 2022-08-15 | $72.48K 10-Q · filed 2022-08-15 | $80.24K derived: sum of 3 quarters · filed 2022-08-15 | $105.21K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $60.31K 10-Q · filed 2022-05-16 | $68.08K derived: sum of 2 quarters · filed 2022-05-16 | $93.05K derived: sum of 3 quarters · filed 2022-05-16 | $111.79K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $7.77K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $32.73K derived: sum of 2 quarters · filed 2022-03-31 | $51.47K derived: sum of 3 quarters · filed 2022-03-31 | $79.03K 10-K · filed 2022-03-31 |
| 2020-09-30 | $24.97K 10-Q · filed 2021-11-15 | $43.70K derived: sum of 2 quarters · filed 2021-11-15 | $71.27K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $18.74K 10-Q · filed 2021-08-16 | $46.30K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $27.56K 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $133.66K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |